Potent cytotoxicity and inhibition of pan-cell cycle progression by an alkylating anthraquinone
申请人:Epenetos Antoniou Agamemnon
公开号:US20070208085A1
公开(公告)日:2007-09-06
The present invention generally relates to chemotherapeutic treatment of proliferative disorders, such as cancer. The invention more specifically relates to inhibition of pan-cell cycle progression with alkylating anthraquinones, which may inhibit mitotic commitment, lead to limited expression of G2 arrest and force cells to enter polyploidy via an aberrant mitosis. The methods of the invention are particularly useful in the treatment of chemotherapy-resistant cancers.